Review



mouse anti mcsp ng2  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Santa Cruz Biotechnology mouse anti mcsp ng2
    Mouse Anti Mcsp Ng2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 201 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti mcsp ng2/product/Santa Cruz Biotechnology
    Average 94 stars, based on 201 article reviews
    mouse anti mcsp ng2 - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    93
    R&D Systems mouse anti human antibody
    Mouse Anti Human Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mouse anti human antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    91
    Novus Biologicals anti mouse ng2 mcsp
    Anti Mouse Ng2 Mcsp, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse ng2 mcsp/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    anti mouse ng2 mcsp - by Bioz Stars, 2026-02
    91/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology mouse anti mcsp ng2
    Mouse Anti Mcsp Ng2, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti mcsp ng2/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    mouse anti mcsp ng2 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    96
    R&D Systems ng2
    a Three-dimensional (3D) wholemount immunostaining with αSMA, CD31 and <t>NG2</t> of E10.5 (31–38 somite pairs (sp)) WT dorsal aorta; b NG2 and Runx1 expression on single plane wholemount WT E10.5 sections. NG2 + Runx1 + vSMCs (arrows), hemogenic endothelial cells (arrowheads) and intra-aortic hematopoietic clusters (IAHCs, stars) (Table ); c Representative example of flow cytometric analysis of NG2 + Runx1(GFP) + (green box) in E10.5 Runx1-IRES-GFP AGM and E10.5 WT control. d Percentages of NG2 + Runx1(GFP) + cells in E9 (21-25sp) body ( n = 6), E10/E10.5/E11 AGMs ( n = 8/7/7), N = 5, Kruskal-Wallis and Dunn’s post-hoc test. e Representative examples of wholemount 3D-images showing αSMA, CD31 and NG2 in E10.5 cKO dorsal aortae; f αSMA, Runx1 and CD31 immunofluorescence of E11 WT and cKO transversal frozen sections; n = WT/cKO: 2/2, N = 2. g cKit and CD31 wholemount 3D-images in E10.5 WT and cKO AGM; h Number of intra-aortic hematopoietic clusters (IAHCs) in E10.5 AGM; n = WT/KO: 5/4, N = 4. Number of colony forming unit-culture (CFU-C) in i E10.5 (31-38sp) AGM; n = WT/HET/KO: 14/10/5 embryos; N = 7 and j E11 (43–52sp) AGM; n = WT/HET/KO: 22/8/19 embryos; N = 11; one-way ANOVA and Tukey’s post-hoc test (Table ). k Percentages of donor cell chimerism 4-months post-transplantation of 6 E11 WT (NG2 +/+ ;Runx1 fl/+ or NG2 +/+ ;Runx1 fl/fl ) , 7 HET ( NG2-Cre;Runx1 fl/+ ) and 6 cKO AGMs ( NG2-Cre;Runx1 fl/fl ) into sub-lethally adult irradiated recipients (1xAGM cells transplanted/recipient; N = 4). Each dot represents one recipient. Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood (dashed line) ; one-tailed Z score test for two population proportions (Tables and ). For wholemount staining in a , b , e , g : WT/cKO ( N = 6/4): αSMA ( n = 9/7), CD31 ( n = 10/7), cKit ( n = 3/2), NG2 ( n = 3/1) and WT Runx1 ( n = 4) in 3 distinct combinations (Table ). D = dorsal, V = ventral. N = number of independent experiments; n = number of biological samples (embryos). All data are presented as mean values ± SEM. Source data for d , h , i , j and k are provided as a file.
    Ng2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ng2/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    ng2 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    93
    R&D Systems mouse anti human mcsp
    Fig. 1. Working scheme of tracking EMT-like phenotype switching during MAPKi therapy. (A) Melanoma cells undergo EMT-like phenotype switching in response to MAPKi therapy and secret EVs into blood circulation. (B) Serum EVs are captured by <t>anti-MCSP</t> and anti-MCAM antibodies immobilized on an electrode and subsequently labeled with SERS nanotags against EMT-associated biomarkers N-cadherin, E-cadherin, THBS1 and ABCB5 under the applied ac-EHD field. (C) EV phenotypes are characterized by SERS mapping. Under the laser excitation, SERS nanotags with MBA, TFMBA, DTNB, and MPY molecules generate characteristic peaks at 1075, 1375, 1335, and 1005 cm−1, respectively. The false-color SERS spectral images are established based on the characteristic Raman signals of four SERS nanotags, indicating the expression of four biomarkers (N-cadherin-MBA, red; E-cadherin-TFMBA, blue; THBS1-DTNB, green; ABCB5-MPY, yellow). The expression levels of four target biomarkers are determined by calculating the average signal spectra of false-color SERS spectral images. (D) EMT-associated EV phenotypic evolution in response to MAPKi treatment.
    Mouse Anti Human Mcsp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti human mcsp/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    mouse anti human mcsp - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    96
    R&D Systems rat anti ng2 antibody
    Fig. 1. Working scheme of tracking EMT-like phenotype switching during MAPKi therapy. (A) Melanoma cells undergo EMT-like phenotype switching in response to MAPKi therapy and secret EVs into blood circulation. (B) Serum EVs are captured by <t>anti-MCSP</t> and anti-MCAM antibodies immobilized on an electrode and subsequently labeled with SERS nanotags against EMT-associated biomarkers N-cadherin, E-cadherin, THBS1 and ABCB5 under the applied ac-EHD field. (C) EV phenotypes are characterized by SERS mapping. Under the laser excitation, SERS nanotags with MBA, TFMBA, DTNB, and MPY molecules generate characteristic peaks at 1075, 1375, 1335, and 1005 cm−1, respectively. The false-color SERS spectral images are established based on the characteristic Raman signals of four SERS nanotags, indicating the expression of four biomarkers (N-cadherin-MBA, red; E-cadherin-TFMBA, blue; THBS1-DTNB, green; ABCB5-MPY, yellow). The expression levels of four target biomarkers are determined by calculating the average signal spectra of false-color SERS spectral images. (D) EMT-associated EV phenotypic evolution in response to MAPKi treatment.
    Rat Anti Ng2 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat anti ng2 antibody/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    rat anti ng2 antibody - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    R&D Systems mab6689
    Fig. 1. Working scheme of tracking EMT-like phenotype switching during MAPKi therapy. (A) Melanoma cells undergo EMT-like phenotype switching in response to MAPKi therapy and secret EVs into blood circulation. (B) Serum EVs are captured by <t>anti-MCSP</t> and anti-MCAM antibodies immobilized on an electrode and subsequently labeled with SERS nanotags against EMT-associated biomarkers N-cadherin, E-cadherin, THBS1 and ABCB5 under the applied ac-EHD field. (C) EV phenotypes are characterized by SERS mapping. Under the laser excitation, SERS nanotags with MBA, TFMBA, DTNB, and MPY molecules generate characteristic peaks at 1075, 1375, 1335, and 1005 cm−1, respectively. The false-color SERS spectral images are established based on the characteristic Raman signals of four SERS nanotags, indicating the expression of four biomarkers (N-cadherin-MBA, red; E-cadherin-TFMBA, blue; THBS1-DTNB, green; ABCB5-MPY, yellow). The expression levels of four target biomarkers are determined by calculating the average signal spectra of false-color SERS spectral images. (D) EMT-associated EV phenotypic evolution in response to MAPKi treatment.
    Mab6689, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mab6689/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    mab6689 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    96
    R&D Systems anti ng2
    Fig. 1. Working scheme of tracking EMT-like phenotype switching during MAPKi therapy. (A) Melanoma cells undergo EMT-like phenotype switching in response to MAPKi therapy and secret EVs into blood circulation. (B) Serum EVs are captured by <t>anti-MCSP</t> and anti-MCAM antibodies immobilized on an electrode and subsequently labeled with SERS nanotags against EMT-associated biomarkers N-cadherin, E-cadherin, THBS1 and ABCB5 under the applied ac-EHD field. (C) EV phenotypes are characterized by SERS mapping. Under the laser excitation, SERS nanotags with MBA, TFMBA, DTNB, and MPY molecules generate characteristic peaks at 1075, 1375, 1335, and 1005 cm−1, respectively. The false-color SERS spectral images are established based on the characteristic Raman signals of four SERS nanotags, indicating the expression of four biomarkers (N-cadherin-MBA, red; E-cadherin-TFMBA, blue; THBS1-DTNB, green; ABCB5-MPY, yellow). The expression levels of four target biomarkers are determined by calculating the average signal spectra of false-color SERS spectral images. (D) EMT-associated EV phenotypic evolution in response to MAPKi treatment.
    Anti Ng2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ng2/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    anti ng2 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    Image Search Results


    a Three-dimensional (3D) wholemount immunostaining with αSMA, CD31 and NG2 of E10.5 (31–38 somite pairs (sp)) WT dorsal aorta; b NG2 and Runx1 expression on single plane wholemount WT E10.5 sections. NG2 + Runx1 + vSMCs (arrows), hemogenic endothelial cells (arrowheads) and intra-aortic hematopoietic clusters (IAHCs, stars) (Table ); c Representative example of flow cytometric analysis of NG2 + Runx1(GFP) + (green box) in E10.5 Runx1-IRES-GFP AGM and E10.5 WT control. d Percentages of NG2 + Runx1(GFP) + cells in E9 (21-25sp) body ( n = 6), E10/E10.5/E11 AGMs ( n = 8/7/7), N = 5, Kruskal-Wallis and Dunn’s post-hoc test. e Representative examples of wholemount 3D-images showing αSMA, CD31 and NG2 in E10.5 cKO dorsal aortae; f αSMA, Runx1 and CD31 immunofluorescence of E11 WT and cKO transversal frozen sections; n = WT/cKO: 2/2, N = 2. g cKit and CD31 wholemount 3D-images in E10.5 WT and cKO AGM; h Number of intra-aortic hematopoietic clusters (IAHCs) in E10.5 AGM; n = WT/KO: 5/4, N = 4. Number of colony forming unit-culture (CFU-C) in i E10.5 (31-38sp) AGM; n = WT/HET/KO: 14/10/5 embryos; N = 7 and j E11 (43–52sp) AGM; n = WT/HET/KO: 22/8/19 embryos; N = 11; one-way ANOVA and Tukey’s post-hoc test (Table ). k Percentages of donor cell chimerism 4-months post-transplantation of 6 E11 WT (NG2 +/+ ;Runx1 fl/+ or NG2 +/+ ;Runx1 fl/fl ) , 7 HET ( NG2-Cre;Runx1 fl/+ ) and 6 cKO AGMs ( NG2-Cre;Runx1 fl/fl ) into sub-lethally adult irradiated recipients (1xAGM cells transplanted/recipient; N = 4). Each dot represents one recipient. Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood (dashed line) ; one-tailed Z score test for two population proportions (Tables and ). For wholemount staining in a , b , e , g : WT/cKO ( N = 6/4): αSMA ( n = 9/7), CD31 ( n = 10/7), cKit ( n = 3/2), NG2 ( n = 3/1) and WT Runx1 ( n = 4) in 3 distinct combinations (Table ). D = dorsal, V = ventral. N = number of independent experiments; n = number of biological samples (embryos). All data are presented as mean values ± SEM. Source data for d , h , i , j and k are provided as a file.

    Journal: Nature Communications

    Article Title: Runx1+ vascular smooth muscle cells are essential for hematopoietic stem and progenitor cell development in vivo

    doi: 10.1038/s41467-024-44913-z

    Figure Lengend Snippet: a Three-dimensional (3D) wholemount immunostaining with αSMA, CD31 and NG2 of E10.5 (31–38 somite pairs (sp)) WT dorsal aorta; b NG2 and Runx1 expression on single plane wholemount WT E10.5 sections. NG2 + Runx1 + vSMCs (arrows), hemogenic endothelial cells (arrowheads) and intra-aortic hematopoietic clusters (IAHCs, stars) (Table ); c Representative example of flow cytometric analysis of NG2 + Runx1(GFP) + (green box) in E10.5 Runx1-IRES-GFP AGM and E10.5 WT control. d Percentages of NG2 + Runx1(GFP) + cells in E9 (21-25sp) body ( n = 6), E10/E10.5/E11 AGMs ( n = 8/7/7), N = 5, Kruskal-Wallis and Dunn’s post-hoc test. e Representative examples of wholemount 3D-images showing αSMA, CD31 and NG2 in E10.5 cKO dorsal aortae; f αSMA, Runx1 and CD31 immunofluorescence of E11 WT and cKO transversal frozen sections; n = WT/cKO: 2/2, N = 2. g cKit and CD31 wholemount 3D-images in E10.5 WT and cKO AGM; h Number of intra-aortic hematopoietic clusters (IAHCs) in E10.5 AGM; n = WT/KO: 5/4, N = 4. Number of colony forming unit-culture (CFU-C) in i E10.5 (31-38sp) AGM; n = WT/HET/KO: 14/10/5 embryos; N = 7 and j E11 (43–52sp) AGM; n = WT/HET/KO: 22/8/19 embryos; N = 11; one-way ANOVA and Tukey’s post-hoc test (Table ). k Percentages of donor cell chimerism 4-months post-transplantation of 6 E11 WT (NG2 +/+ ;Runx1 fl/+ or NG2 +/+ ;Runx1 fl/fl ) , 7 HET ( NG2-Cre;Runx1 fl/+ ) and 6 cKO AGMs ( NG2-Cre;Runx1 fl/fl ) into sub-lethally adult irradiated recipients (1xAGM cells transplanted/recipient; N = 4). Each dot represents one recipient. Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood (dashed line) ; one-tailed Z score test for two population proportions (Tables and ). For wholemount staining in a , b , e , g : WT/cKO ( N = 6/4): αSMA ( n = 9/7), CD31 ( n = 10/7), cKit ( n = 3/2), NG2 ( n = 3/1) and WT Runx1 ( n = 4) in 3 distinct combinations (Table ). D = dorsal, V = ventral. N = number of independent experiments; n = number of biological samples (embryos). All data are presented as mean values ± SEM. Source data for d , h , i , j and k are provided as a file.

    Article Snippet: The following unconjugated primary antibodies were incubated overnight at 4 °C: NG2 (1:100, Rabbit polyclonal, Millipore, ab5320), NG2 (1:50, Rat anti-mouse, R&D systems, MAB6689), Rabbit anti-RFP to detect TdTomato (1:100, Rockland, 600-401-379), CD45 (1:100, Goat anti-mouse, R&D systems, AF114), F4/80 (1:50, Rat anti-mouse, Abcam, ab6640), and Runx1,2,3 (1:100, Rabbit anti-mouse, Abcam, ab92336).

    Techniques: Immunostaining, Expressing, Control, Immunofluorescence, Transplantation Assay, Irradiation, One-tailed Test, Staining

    a t-SNE plot highlighting eight populations of interest identified in the E11 WT AGM. Each dot represents one cell and colours represent cell clusters as indicated. The number of cells in each population is shown in brackets. MP (macrophages); Ery/EryP (erythroid/progenitors); IAHC (intra-aortic hematopoietic clusters); HEC/EHT (hemogenic endothelial cells including those that enter endothelial-to-hematopoietic transition); EC (endothelial cells); SNS (sympathetic nervous system); SkMP (skeletal muscle progenitors), PC/vSMC (pericytes/vascular smooth muscle cells, NG2 + Acta2 + ). Other cells (OC) are coloured in grey. b t-SNE plot highlighting the eight populations identified after excluding all other (grey) cells. c Zoom into PC/vSMC cluster (black rectangle) further show the presence or the absence of selected genes that characterise this population and confirms the presence of Runx1 in a subset of cells. d Violin plots showing distribution of expression for selected genes that contributed to the identification of cell clusters. Immunohistochemistry on frozen E11 WT sections stained with e CD146/CD31/DAPI and f CD146/αSMA/DAPI, n = 2 samples tested, N = 2 independent experiments. Arrows: vascular cells, asterisks: perivascular cells. DA: dorsal aorta, CV: cardinal veins, NC: notochord. Source data for e (first column, 20X) is provided as a file.

    Journal: Nature Communications

    Article Title: Runx1+ vascular smooth muscle cells are essential for hematopoietic stem and progenitor cell development in vivo

    doi: 10.1038/s41467-024-44913-z

    Figure Lengend Snippet: a t-SNE plot highlighting eight populations of interest identified in the E11 WT AGM. Each dot represents one cell and colours represent cell clusters as indicated. The number of cells in each population is shown in brackets. MP (macrophages); Ery/EryP (erythroid/progenitors); IAHC (intra-aortic hematopoietic clusters); HEC/EHT (hemogenic endothelial cells including those that enter endothelial-to-hematopoietic transition); EC (endothelial cells); SNS (sympathetic nervous system); SkMP (skeletal muscle progenitors), PC/vSMC (pericytes/vascular smooth muscle cells, NG2 + Acta2 + ). Other cells (OC) are coloured in grey. b t-SNE plot highlighting the eight populations identified after excluding all other (grey) cells. c Zoom into PC/vSMC cluster (black rectangle) further show the presence or the absence of selected genes that characterise this population and confirms the presence of Runx1 in a subset of cells. d Violin plots showing distribution of expression for selected genes that contributed to the identification of cell clusters. Immunohistochemistry on frozen E11 WT sections stained with e CD146/CD31/DAPI and f CD146/αSMA/DAPI, n = 2 samples tested, N = 2 independent experiments. Arrows: vascular cells, asterisks: perivascular cells. DA: dorsal aorta, CV: cardinal veins, NC: notochord. Source data for e (first column, 20X) is provided as a file.

    Article Snippet: The following unconjugated primary antibodies were incubated overnight at 4 °C: NG2 (1:100, Rabbit polyclonal, Millipore, ab5320), NG2 (1:50, Rat anti-mouse, R&D systems, MAB6689), Rabbit anti-RFP to detect TdTomato (1:100, Rockland, 600-401-379), CD45 (1:100, Goat anti-mouse, R&D systems, AF114), F4/80 (1:50, Rat anti-mouse, Abcam, ab6640), and Runx1,2,3 (1:100, Rabbit anti-mouse, Abcam, ab92336).

    Techniques: Expressing, Immunohistochemistry, Staining

    a t-SNE plots showing the distribution of Runx1 and Acta2 expression in NG2 + Runx1 + cells in the WT E11 AGM after excluding all other (grey) cells found in the Fig. . b Zoom into NG2 + Runx1 + cluster (black rectangle) shows the presence or the absence of Acta2 . c Heatmap showing the expression of Cspg4 and Runx1 and 15 selected genes out of 25 top significantly upregulated genes in WT NG2 + Runx1 + Acta2 + cells (upper half) and NG2 + Runx1 + Acta2 - cells (bottom half) at single cell level; *Runx1 potential target genes. Pdgfra and Ptn genes were next added to inform their expression in both populations. Barplot of fold enrichment for selected GO biological processes significantly overrepresented in genes significantly upregulated in both d WT NG2 + Runx1 + Acta2 + and e NG2 + Runx1 + Acta2 - cells. f t-SNE of WT E11 AGM cells, overlaid with principal pseudotime curve inferred by Slingshot, predicting a lineage from NG2 + Runx1 + Acta2 - cells to NG2 + Runx1 + Acta2 + cells. g WT NG2 + Runx1 + cells arranged in pseudotime (x-axis) based on the inferred curve. Y-axis represents log normalised gene expression.

    Journal: Nature Communications

    Article Title: Runx1+ vascular smooth muscle cells are essential for hematopoietic stem and progenitor cell development in vivo

    doi: 10.1038/s41467-024-44913-z

    Figure Lengend Snippet: a t-SNE plots showing the distribution of Runx1 and Acta2 expression in NG2 + Runx1 + cells in the WT E11 AGM after excluding all other (grey) cells found in the Fig. . b Zoom into NG2 + Runx1 + cluster (black rectangle) shows the presence or the absence of Acta2 . c Heatmap showing the expression of Cspg4 and Runx1 and 15 selected genes out of 25 top significantly upregulated genes in WT NG2 + Runx1 + Acta2 + cells (upper half) and NG2 + Runx1 + Acta2 - cells (bottom half) at single cell level; *Runx1 potential target genes. Pdgfra and Ptn genes were next added to inform their expression in both populations. Barplot of fold enrichment for selected GO biological processes significantly overrepresented in genes significantly upregulated in both d WT NG2 + Runx1 + Acta2 + and e NG2 + Runx1 + Acta2 - cells. f t-SNE of WT E11 AGM cells, overlaid with principal pseudotime curve inferred by Slingshot, predicting a lineage from NG2 + Runx1 + Acta2 - cells to NG2 + Runx1 + Acta2 + cells. g WT NG2 + Runx1 + cells arranged in pseudotime (x-axis) based on the inferred curve. Y-axis represents log normalised gene expression.

    Article Snippet: The following unconjugated primary antibodies were incubated overnight at 4 °C: NG2 (1:100, Rabbit polyclonal, Millipore, ab5320), NG2 (1:50, Rat anti-mouse, R&D systems, MAB6689), Rabbit anti-RFP to detect TdTomato (1:100, Rockland, 600-401-379), CD45 (1:100, Goat anti-mouse, R&D systems, AF114), F4/80 (1:50, Rat anti-mouse, Abcam, ab6640), and Runx1,2,3 (1:100, Rabbit anti-mouse, Abcam, ab92336).

    Techniques: Expressing, Gene Expression

    a t-SNE plot showing eight populations of interest found in the E11 cKO AGM. Each dot represents one cell and colours represent cell clusters as indicated. MP (macrophages); Ery/EryP (erythroid/progenitors); IAHC (intra-aortic hematopoietic clusters); HEC/EHT (hemogenic endothelial cells including those that enter endothelial-to-hematopoietic transition), EC (endothelial cells); SNS (sympathetic nervous system); SkMP (skeletal muscle progenitors); PC/vSMC (pericytes/vascular smooth muscle cells, NG2 + Acta2 + ) . Other cells (OC) are coloured in grey. The number of cells in each cluster is shown in brackets. b t-SNE plot highlighting the eight populations identified after excluding all other (grey) cells. c Percentage of single live cells found in each E11 AGM sample (cell number/total cells) defined by scRNA-seq in WT (full bars) and cKO (empty bars) AGMs. Colours and numbers correspond to each population defined in a ; chi-squared two-tailed test was used for comparison. d Barplot of fold enrichment for selected GO biological processes significantly overrepresented in genes significantly downregulated in cKO PC/vSMCs compared to their WT counterparts. Heatmap of ligand-receptor interactions inferred by NicheNet from e WT and f cKO E11 AGM cells. Colour represents the interaction potential score between the 10 top-ranked ligands expressed in ECs and their inferred targets expressed in PC/vSMCs. Ligands and receptors are ordered by hierarchical clustering. g Scatter plots of AUC vs –log10(FDR) showing downregulated genes associated with selected GO terms in cKO PC/vSMCs. Red dots represent significantly downregulated genes (FDR<0.05); dashed line shows FDR = 0.05. Gene labels with red borders represent potential Runx1 target genes.

    Journal: Nature Communications

    Article Title: Runx1+ vascular smooth muscle cells are essential for hematopoietic stem and progenitor cell development in vivo

    doi: 10.1038/s41467-024-44913-z

    Figure Lengend Snippet: a t-SNE plot showing eight populations of interest found in the E11 cKO AGM. Each dot represents one cell and colours represent cell clusters as indicated. MP (macrophages); Ery/EryP (erythroid/progenitors); IAHC (intra-aortic hematopoietic clusters); HEC/EHT (hemogenic endothelial cells including those that enter endothelial-to-hematopoietic transition), EC (endothelial cells); SNS (sympathetic nervous system); SkMP (skeletal muscle progenitors); PC/vSMC (pericytes/vascular smooth muscle cells, NG2 + Acta2 + ) . Other cells (OC) are coloured in grey. The number of cells in each cluster is shown in brackets. b t-SNE plot highlighting the eight populations identified after excluding all other (grey) cells. c Percentage of single live cells found in each E11 AGM sample (cell number/total cells) defined by scRNA-seq in WT (full bars) and cKO (empty bars) AGMs. Colours and numbers correspond to each population defined in a ; chi-squared two-tailed test was used for comparison. d Barplot of fold enrichment for selected GO biological processes significantly overrepresented in genes significantly downregulated in cKO PC/vSMCs compared to their WT counterparts. Heatmap of ligand-receptor interactions inferred by NicheNet from e WT and f cKO E11 AGM cells. Colour represents the interaction potential score between the 10 top-ranked ligands expressed in ECs and their inferred targets expressed in PC/vSMCs. Ligands and receptors are ordered by hierarchical clustering. g Scatter plots of AUC vs –log10(FDR) showing downregulated genes associated with selected GO terms in cKO PC/vSMCs. Red dots represent significantly downregulated genes (FDR<0.05); dashed line shows FDR = 0.05. Gene labels with red borders represent potential Runx1 target genes.

    Article Snippet: The following unconjugated primary antibodies were incubated overnight at 4 °C: NG2 (1:100, Rabbit polyclonal, Millipore, ab5320), NG2 (1:50, Rat anti-mouse, R&D systems, MAB6689), Rabbit anti-RFP to detect TdTomato (1:100, Rockland, 600-401-379), CD45 (1:100, Goat anti-mouse, R&D systems, AF114), F4/80 (1:50, Rat anti-mouse, Abcam, ab6640), and Runx1,2,3 (1:100, Rabbit anti-mouse, Abcam, ab92336).

    Techniques: Two Tailed Test, Comparison

    a , b Representative plots and percentages of Lin - Sca1 + cKit + (LSK) and c , d LSK CD150 + CD48 - (SLAM) bone marrow (BM) cells by flow cytometry of WT/ NG2+/+;Runx1 fl/+ ,NG2+/+;Runx1 fl/fl ( n = 9), HET NG2-Cre;Runx1 fl/+ ( n = 4) and cKO NG2-Cre;Runx1 fl/fl ( n = 4) adult mice is shown. e Colony-forming unit-culture (CFU-C) numbers per 10 adult BM cells; n = WT/HET/cKO: 13/7/8 mice. N = 7 independent experiments. Data are mean ± SEM (Table ). f Hematopoietic stem cell repopulating potential and donor chimerism of WT and mutant BM cells in vivo. 5 × 10 5 BM donor WT, HET and cKO cells were injected into 29, 11 and 20 Ly5.1 HET recipients, respectively, with 18, 3 and 4 found to be reconstituted respectively (Table S3, p = 0.024 (WT/HET) and p = 0.002 (WT/cKO) by Z score test for 2 population proportions). Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood; p = 0.002 (WT/cKO) by Kruskal-Wallis and Dunn’s post-hoc test (Table ). g Histograms showing the contribution of CD45.2 + CD45.1 - donor cells to myeloid cells (CD11b + Gr1 +/- ), B cells (CD19 + ) and T cells (CD4/8 + ) in all reconstituted host mice from ( f ). ( n = WT/HET/cKO = 18/3/4), p = 0.019 (WT/HET) for B cells by one-way ANOVA and Tukey’s post-hoc test. h BM cells from selected reconstituted primary recipients (found in f ) were transplanted into multiple irradiated secondary recipients. Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood (Table – ). i Representative flow cytometric analysis plot of NG2 in Runx1-IRES-GFP adult BM ( n = 6). All data are presented as Mean values+/-SEM. N = number of independent experiments; n = number of biological samples. Source data for b , d , e , f , g and h are provided as a file.

    Journal: Nature Communications

    Article Title: Runx1+ vascular smooth muscle cells are essential for hematopoietic stem and progenitor cell development in vivo

    doi: 10.1038/s41467-024-44913-z

    Figure Lengend Snippet: a , b Representative plots and percentages of Lin - Sca1 + cKit + (LSK) and c , d LSK CD150 + CD48 - (SLAM) bone marrow (BM) cells by flow cytometry of WT/ NG2+/+;Runx1 fl/+ ,NG2+/+;Runx1 fl/fl ( n = 9), HET NG2-Cre;Runx1 fl/+ ( n = 4) and cKO NG2-Cre;Runx1 fl/fl ( n = 4) adult mice is shown. e Colony-forming unit-culture (CFU-C) numbers per 10 adult BM cells; n = WT/HET/cKO: 13/7/8 mice. N = 7 independent experiments. Data are mean ± SEM (Table ). f Hematopoietic stem cell repopulating potential and donor chimerism of WT and mutant BM cells in vivo. 5 × 10 5 BM donor WT, HET and cKO cells were injected into 29, 11 and 20 Ly5.1 HET recipients, respectively, with 18, 3 and 4 found to be reconstituted respectively (Table S3, p = 0.024 (WT/HET) and p = 0.002 (WT/cKO) by Z score test for 2 population proportions). Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood; p = 0.002 (WT/cKO) by Kruskal-Wallis and Dunn’s post-hoc test (Table ). g Histograms showing the contribution of CD45.2 + CD45.1 - donor cells to myeloid cells (CD11b + Gr1 +/- ), B cells (CD19 + ) and T cells (CD4/8 + ) in all reconstituted host mice from ( f ). ( n = WT/HET/cKO = 18/3/4), p = 0.019 (WT/HET) for B cells by one-way ANOVA and Tukey’s post-hoc test. h BM cells from selected reconstituted primary recipients (found in f ) were transplanted into multiple irradiated secondary recipients. Mice are reconstituted when ≥5% donor cells are found in the host peripheral blood (Table – ). i Representative flow cytometric analysis plot of NG2 in Runx1-IRES-GFP adult BM ( n = 6). All data are presented as Mean values+/-SEM. N = number of independent experiments; n = number of biological samples. Source data for b , d , e , f , g and h are provided as a file.

    Article Snippet: The following unconjugated primary antibodies were incubated overnight at 4 °C: NG2 (1:100, Rabbit polyclonal, Millipore, ab5320), NG2 (1:50, Rat anti-mouse, R&D systems, MAB6689), Rabbit anti-RFP to detect TdTomato (1:100, Rockland, 600-401-379), CD45 (1:100, Goat anti-mouse, R&D systems, AF114), F4/80 (1:50, Rat anti-mouse, Abcam, ab6640), and Runx1,2,3 (1:100, Rabbit anti-mouse, Abcam, ab92336).

    Techniques: Flow Cytometry, Mutagenesis, In Vivo, Injection, Irradiation

    Fig. 1. Working scheme of tracking EMT-like phenotype switching during MAPKi therapy. (A) Melanoma cells undergo EMT-like phenotype switching in response to MAPKi therapy and secret EVs into blood circulation. (B) Serum EVs are captured by anti-MCSP and anti-MCAM antibodies immobilized on an electrode and subsequently labeled with SERS nanotags against EMT-associated biomarkers N-cadherin, E-cadherin, THBS1 and ABCB5 under the applied ac-EHD field. (C) EV phenotypes are characterized by SERS mapping. Under the laser excitation, SERS nanotags with MBA, TFMBA, DTNB, and MPY molecules generate characteristic peaks at 1075, 1375, 1335, and 1005 cm−1, respectively. The false-color SERS spectral images are established based on the characteristic Raman signals of four SERS nanotags, indicating the expression of four biomarkers (N-cadherin-MBA, red; E-cadherin-TFMBA, blue; THBS1-DTNB, green; ABCB5-MPY, yellow). The expression levels of four target biomarkers are determined by calculating the average signal spectra of false-color SERS spectral images. (D) EMT-associated EV phenotypic evolution in response to MAPKi treatment.

    Journal: Biosensors & bioelectronics

    Article Title: Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes.

    doi: 10.1016/j.bios.2023.115819

    Figure Lengend Snippet: Fig. 1. Working scheme of tracking EMT-like phenotype switching during MAPKi therapy. (A) Melanoma cells undergo EMT-like phenotype switching in response to MAPKi therapy and secret EVs into blood circulation. (B) Serum EVs are captured by anti-MCSP and anti-MCAM antibodies immobilized on an electrode and subsequently labeled with SERS nanotags against EMT-associated biomarkers N-cadherin, E-cadherin, THBS1 and ABCB5 under the applied ac-EHD field. (C) EV phenotypes are characterized by SERS mapping. Under the laser excitation, SERS nanotags with MBA, TFMBA, DTNB, and MPY molecules generate characteristic peaks at 1075, 1375, 1335, and 1005 cm−1, respectively. The false-color SERS spectral images are established based on the characteristic Raman signals of four SERS nanotags, indicating the expression of four biomarkers (N-cadherin-MBA, red; E-cadherin-TFMBA, blue; THBS1-DTNB, green; ABCB5-MPY, yellow). The expression levels of four target biomarkers are determined by calculating the average signal spectra of false-color SERS spectral images. (D) EMT-associated EV phenotypic evolution in response to MAPKi treatment.

    Article Snippet: The primary antibodies were mouse anti-human MCSP (R&D Systems, MAB2585) and MCAM (R&D Systems, MAB932) antibodies.

    Techniques: Labeling, Expressing

    Fig. 3. Specificity of the SERS-based microfluidic biosensor. Representative SERS false-color spectral images and average SERS intensities of EVs derived from SK-MEL-28 (high expression of MCSP and MCAM) and MCF7 (low expression of MCSP and MCAM) cell lines, and control experiments including (++) PBS, (-+) without capture antibodies and (+-) with nontarget IgG antibody on SERS nanotags. EV biomarkers are represented by red (N-cadherin), blue (E-cadherin), green (THBS1) and yellow (ABCB5). Average SERS intensities were generated at 1075 cm−1 (N-cadherin), 1375 cm−1 (E-cadherin), 1335 cm−1 (THBS1), and 1005 cm−1

    Journal: Biosensors & bioelectronics

    Article Title: Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes.

    doi: 10.1016/j.bios.2023.115819

    Figure Lengend Snippet: Fig. 3. Specificity of the SERS-based microfluidic biosensor. Representative SERS false-color spectral images and average SERS intensities of EVs derived from SK-MEL-28 (high expression of MCSP and MCAM) and MCF7 (low expression of MCSP and MCAM) cell lines, and control experiments including (++) PBS, (-+) without capture antibodies and (+-) with nontarget IgG antibody on SERS nanotags. EV biomarkers are represented by red (N-cadherin), blue (E-cadherin), green (THBS1) and yellow (ABCB5). Average SERS intensities were generated at 1075 cm−1 (N-cadherin), 1375 cm−1 (E-cadherin), 1335 cm−1 (THBS1), and 1005 cm−1

    Article Snippet: The primary antibodies were mouse anti-human MCSP (R&D Systems, MAB2585) and MCAM (R&D Systems, MAB932) antibodies.

    Techniques: Derivative Assay, Expressing, Control, Generated

    Fig. 2. Characterization of EVs derived from melanoma (SK-MEL-28) and breast cancer (MCF7) cell lines. (A) The expression of canonical tetraspanin CD63 and (B) size distributions of SK-MEL-28 and MCF7 EVs using nanoflow cytometry. (C) The expression of melanoma-specific biomarkers MCSP and MCAM on SK-MEL- 28 and MCF7 EVs, measured by western blot.

    Journal: Biosensors & bioelectronics

    Article Title: Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes.

    doi: 10.1016/j.bios.2023.115819

    Figure Lengend Snippet: Fig. 2. Characterization of EVs derived from melanoma (SK-MEL-28) and breast cancer (MCF7) cell lines. (A) The expression of canonical tetraspanin CD63 and (B) size distributions of SK-MEL-28 and MCF7 EVs using nanoflow cytometry. (C) The expression of melanoma-specific biomarkers MCSP and MCAM on SK-MEL- 28 and MCF7 EVs, measured by western blot.

    Article Snippet: The primary antibodies were mouse anti-human MCSP (R&D Systems, MAB2585) and MCAM (R&D Systems, MAB932) antibodies.

    Techniques: Derivative Assay, Expressing, Cytometry, Western Blot